Lamictal (lamotrigine) monotherapy for typical absence seizures in children.
about
Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescentsEthosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescentsEthosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.Pretreatment EEG in childhood absence epilepsy: associations with attention and treatment outcome.Absence seizures in childrenTypical absence seizures and their treatment.Valproate efficacy in absence seizures is hard to beat: lamotrigine comes close.New anti-epileptic drugs for the 21st century.The management of refractory idiopathic epilepsies.Clinical pharmacology and therapeutic use of the new antiepileptic drugs.A revisited strategy for antiepileptic drug development in children: designing an initial exploratory step.Pediatric partial and generalized seizures.Efficacy and safety of lamotrigine in pediatric patients.Infantile spasms and Lennox-Gastaut syndrome.Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended releaseReview of lamotrigine and its clinical applications in epilepsy.Pharmacotherapy of paediatric epilepsy.Lamotrigine monotherapy for newly diagnosed typical absence seizures in children.Safety of lamotrigine in paediatrics: a systematic review.Characteristics of successful recruitment in prospective pediatric pharmacogenetic studiesChoosing antiepileptic drugs for developmentally normal children with specific epilepsy syndromes and behavioral disorders.Idiopathic generalized epilepsies: clinical and electroencephalogram diagnosis and treatment.Levetiracetam efficacy in idiopathic generalized epilepsy: long suspected and now confirmed in randomized clinical trials.Pharmacological treatment of childhood absence epilepsy.Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 monthsLamotrigine and its applications in the treatment of epilepsy and other neurological and psychiatric disorders.Clinical development of antiepileptic drugs for children.Antiepileptic drug treatment in children.Treatment of epilepsies associated with typical absences.Pharmacotherapy for children and adolescents with epilepsy.Treatment of idiopathic generalized epilepsy - a review of the evidence.Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.Current and emerging treatments for absence seizures in young patientsEthosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.How to optimise drug study design: pharmacokinetics and pharmacodynamics studies introduced to paediatricians.A pharmacological overview of lamotrigine for the treatment of epilepsy.The current state of absence epilepsy: can we have your attention?Treatment of childhood absence epilepsy-an evidence-based answer at last!Long-term tolerability and efficacy of lamotrigine in pediatric patients with epilepsy.Lamotrigine ameliorates seizures and psychiatric comorbidity in a rat model of spontaneous absence epilepsy.
P2860
Q24245943-F61967DF-AA69-463C-9E81-A98BBB9D7BB2Q24247993-46556DD2-F3F6-4D7D-82C7-0A3AF0F909FCQ24630240-38D3ECED-B778-4B83-B8E0-E5582C3D56F6Q30544595-0CB46AFE-6183-4510-BCB1-65C150D4DA12Q33446767-4892B375-7AD4-4143-B0CF-1330677AD86AQ33734417-91A3FDF7-F05E-48DE-9C02-248EB6C78EC3Q33899343-0E8759C4-45A3-4C89-9902-90F87CD9588BQ34182061-BFE7F621-5747-4EE6-8B18-DA5A8C588B78Q34345026-2921828B-587D-404E-87F0-FA16940E6B15Q34541736-3EFB642A-9E2A-44F3-8553-2F67C7057FBDQ34560399-172B1267-051D-414C-A0FC-C62177A60A82Q34579465-03A61264-3385-4407-B989-0E91B24D0C0DQ34599692-F0C5BEE8-8640-42B1-A56C-BC8C16C4D313Q34599704-24469FB4-7C8C-4CBA-8D99-399DD4AA2A37Q34942400-050F4BBE-1335-4876-817A-38F21C08BD41Q35058133-FB24013E-57C6-4D09-9CAA-F1051C477011Q35095171-C75B4DA5-991F-4C32-8BD4-DBD5DD31C095Q35619038-78276C52-E688-48E8-8C5C-A599A217D3A2Q35662636-88ED1C04-463D-470A-BDA6-3BFE39C5CF18Q35871392-087484E5-23FC-4944-B4DD-DDDF6CB2A418Q35939596-D138F28B-98AA-4A64-8B21-6A7EBBB7393EQ36307856-D4662367-2249-4876-BB77-1D1A60A7331FQ36453510-5F6F6C50-2BD3-48ED-8187-CA2566AEFC11Q36511313-104001A8-A352-40F6-A004-9707FA7E8BEBQ36514054-6A76CC40-2F91-4081-9209-B34601519CC3Q36673011-F5CF6795-9A93-46F0-8B00-EED87CDFDC34Q36697473-3715463C-421C-436C-9C41-97B62A5BDE43Q36730668-A208CE6D-AECD-43D7-9E6E-F41FD7D69DE8Q37610185-71BE40AA-15F6-4305-9CCF-F01B8F3A1C0BQ37826193-07035FD2-4055-4929-8D28-F2FAF1B3BC69Q38008462-EA996C53-0134-4D3A-AD80-3196DB7008E9Q38076740-9B22C362-BBFC-4C86-B087-D303BDF77ED7Q38124030-8C5CF7DD-65D5-4F1E-A50C-08FBFE658DE5Q38962415-15F9029E-900A-49F6-9CC0-CD28BDFCB21AQ38965300-BA3A4585-AF03-4114-8FBC-CD5C508B8C5AQ39002973-AE1A8FED-9F7E-47CE-A690-851AC3B057E2Q41408430-B8335F1A-A8E2-4468-B122-C1B6DB7AC122Q42205863-BA1B70E2-FE91-4DD8-9F58-C6E1390934EEQ42679270-7BD7604B-2FC6-4986-B700-8DA89BFF32E0Q44495944-6F07BEAD-2EC2-4720-B156-51205E653BFC
P2860
Lamictal (lamotrigine) monotherapy for typical absence seizures in children.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Lamictal (lamotrigine) monotherapy for typical absence seizures in children.
@en
Lamictal
@nl
type
label
Lamictal (lamotrigine) monotherapy for typical absence seizures in children.
@en
Lamictal
@nl
prefLabel
Lamictal (lamotrigine) monotherapy for typical absence seizures in children.
@en
Lamictal
@nl
P2093
P2860
P1433
P1476
Lamictal (lamotrigine) monotherapy for typical absence seizures in children.
@en
P2093
E J Casale
G L Holmes
S Concannon
P2860
P304
P356
10.1111/J.1528-1157.1999.TB00805.X
P577
1999-07-01T00:00:00Z